• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄芪甲苷在癌症治疗中的分子机制(综述)。

Molecular mechanisms of astragaloside‑IV in cancer therapy (Review).

机构信息

Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300380, P.R. China.

出版信息

Int J Mol Med. 2021 Mar;47(3). doi: 10.3892/ijmm.2021.4846. Epub 2021 Jan 15.

DOI:10.3892/ijmm.2021.4846
PMID:33448320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7834967/
Abstract

Radix Astragali (RA) is widely used in traditional Chinese medicine (TCM), and astragaloside IV (AS‑IV) is the most critical component of RA. Previous studies have demonstrated that AS‑IV exerts effects on the myocardium, nervous system and endocrine system, among others. In the present review article, data from studies conducted over the past 20 years were collated, which have evaluated the effects of AS‑IV on tumors. The mechanisms of action of AS‑IV on malignant cells both and were summarized and it was demonstrated that AS‑IV plays a vital role, particularly in inhibiting tumor growth and metastasis, promoting the apoptosis of tumor cells, enhancing immune function and preventing drug resistance. Moreover, AS‑IV controls several epithelial‑mesenchymal transformation (EMT)‑related and autophagy‑related pathways, such as the phosphoinositide‑3‑kinase (PI3K)/protein kinase B (AKT), Wnt/β‑catenin, mitogen‑activated protein kinase (MAPK)/extracellular regulated protein kinase (ERK) and transforming growth factor‑β (TGF‑β)/SMAD signaling pathways, which are commonly affected in the majority of tumors. The present review provides new perspectives on the functions of AS‑IV and its role as an adjuvant treatment in cancer chemotherapy.

摘要

黄芪(RA)在中药(TCM)中被广泛应用,其中黄芪甲苷(AS- IV)是 RA 最关键的成分。先前的研究表明,AS-IV 对心肌、神经系统和内分泌系统等均具有作用。在本综述文章中,整理了过去 20 年来关于 AS-IV 对肿瘤影响的研究数据。总结了 AS-IV 对恶性细胞的作用机制,结果表明 AS-IV 发挥了重要作用,特别是在抑制肿瘤生长和转移、促进肿瘤细胞凋亡、增强免疫功能和防止耐药性方面。此外,AS-IV 还控制着几个上皮-间充质转化(EMT)和自噬相关通路,如磷酸肌醇 3-激酶(PI3K)/蛋白激酶 B(AKT)、Wnt/β-连环蛋白、丝裂原活化蛋白激酶(MAPK)/细胞外调节蛋白激酶(ERK)和转化生长因子-β(TGF-β)/SMAD 信号通路,这些通路在大多数肿瘤中都普遍受到影响。本综述为 AS-IV 的功能及其在癌症化疗中的辅助治疗作用提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bd/7834967/1603895f1e60/IJMM-47-03-4846-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bd/7834967/27c508a6c496/IJMM-47-03-4846-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bd/7834967/c329fef93951/IJMM-47-03-4846-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bd/7834967/55096a8fe7dc/IJMM-47-03-4846-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bd/7834967/1603895f1e60/IJMM-47-03-4846-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bd/7834967/27c508a6c496/IJMM-47-03-4846-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bd/7834967/c329fef93951/IJMM-47-03-4846-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bd/7834967/55096a8fe7dc/IJMM-47-03-4846-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bd/7834967/1603895f1e60/IJMM-47-03-4846-g03.jpg

相似文献

1
Molecular mechanisms of astragaloside‑IV in cancer therapy (Review).黄芪甲苷在癌症治疗中的分子机制(综述)。
Int J Mol Med. 2021 Mar;47(3). doi: 10.3892/ijmm.2021.4846. Epub 2021 Jan 15.
2
Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF‑β1‑mediated PI3K and MAPK pathways.黄芪甲苷通过 TGF-β1 介导的 PI3K 和 MAPK 通路抑制 SiHa 宫颈癌细胞的侵袭和转移。
Oncol Rep. 2019 May;41(5):2975-2986. doi: 10.3892/or.2019.7062. Epub 2019 Mar 13.
3
Anticancer effects and mechanisms of astragaloside‑IV (Review).黄芪甲苷的抗癌作用及其机制(综述)。
Oncol Rep. 2023 Jan;49(1). doi: 10.3892/or.2022.8442. Epub 2022 Nov 11.
4
Astragaloside IV inhibits isoprenaline‑induced cardiac fibrosis by targeting the reactive oxygen species/mitogen‑activated protein kinase signaling axis.黄芪甲苷IV通过靶向活性氧/丝裂原活化蛋白激酶信号轴抑制异丙肾上腺素诱导的心脏纤维化。
Mol Med Rep. 2017 Apr;15(4):1765-1770. doi: 10.3892/mmr.2017.6220. Epub 2017 Feb 17.
5
Astragaloside IV prevents high glucose‑induced cell apoptosis and inflammatory reactions through inhibition of the JNK pathway in human umbilical vein endothelial cells.黄芪甲苷通过抑制 JNK 通路预防高糖诱导的人脐静脉内皮细胞凋亡和炎症反应。
Mol Med Rep. 2019 Mar;19(3):1603-1612. doi: 10.3892/mmr.2019.9812. Epub 2019 Jan 3.
6
Immune regulation mechanism of Astragaloside IV on RAW264.7 cells through activating the NF-κB/MAPK signaling pathway.黄芪甲苷通过激活NF-κB/MAPK信号通路对RAW264.7细胞的免疫调节机制
Int Immunopharmacol. 2017 Aug;49:38-49. doi: 10.1016/j.intimp.2017.05.017. Epub 2017 May 25.
7
[Effect of Combined Intervention of Electroacupuncture and Astragaloside IV on Myocardial Hypertrophy and TGF-β 1/Smad Signaling in Rats with Myocardial Fibrosis].[电针与黄芪甲苷Ⅳ联合干预对心肌纤维化大鼠心肌肥厚及TGF-β 1/Smad信号通路的影响]
Zhen Ci Yan Jiu. 2017 Dec 25;42(6):477-81. doi: 10.13702/j.1000-0607.2017.06.002.
8
Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway.黄芪甲苷对大鼠心肌肥厚具有心肌保护作用,部分通过激活 Nrf2/HO-1 信号通路。
Oxid Med Cell Longev. 2019 Jun 11;2019:4625912. doi: 10.1155/2019/4625912. eCollection 2019.
9
Inhibition of RANKL-induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium-particle-induced osteolysis.通过黄芪甲苷抑制ERK信号通路来抑制RANKL诱导的破骨细胞生成以及减轻钛颗粒诱导的骨溶解
Int J Mol Med. 2015 Nov;36(5):1335-44. doi: 10.3892/ijmm.2015.2330. Epub 2015 Aug 31.
10
Astragaloside IV ameliorates cisplatin-induced liver injury by modulating ferroptosis-dependent pathways.黄芪甲苷通过调节铁死亡依赖的途径改善顺铂诱导的肝损伤。
J Ethnopharmacol. 2024 Jun 28;328:118080. doi: 10.1016/j.jep.2024.118080. Epub 2024 Mar 22.

引用本文的文献

1
Molecular mechanisms of astragaloside-IV in hepatocellular carcinoma therapy: a systematic review.黄芪甲苷在肝细胞癌治疗中的分子机制:一项系统综述
BMC Cancer. 2025 Sep 1;25(1):1407. doi: 10.1186/s12885-025-14758-w.
2
Astragaloside IV: a potential nemesis for gastric cancer.黄芪甲苷IV:胃癌的潜在克星。
Front Pharmacol. 2025 Jul 18;16:1636341. doi: 10.3389/fphar.2025.1636341. eCollection 2025.
3
Exploring Astragaloside IV in Ischemic Heart Disease: A Comprehensive Systematic Review and Meta-Analysis of Preclinical Cardiotoxicity Models.

本文引用的文献

1
Survival Outcomes of Radical Prostatectomy + Extended Pelvic Lymph Node Dissection and Radiotherapy in Prostate Cancer Patients With a Risk of Lymph Node Invasion Over 5%: A Population-Based Analysis.前列腺癌淋巴结侵犯风险超过5%的患者行根治性前列腺切除术+扩大盆腔淋巴结清扫术及放疗后的生存结果:一项基于人群的分析
Front Oncol. 2020 Nov 26;10:607576. doi: 10.3389/fonc.2020.607576. eCollection 2020.
2
The Molecular and Microenvironmental Landscape of Glioblastomas: Implications for the Novel Treatment Choices.胶质母细胞瘤的分子与微环境格局:对新型治疗选择的启示
Front Neurosci. 2020 Nov 25;14:603647. doi: 10.3389/fnins.2020.603647. eCollection 2020.
3
探索黄芪甲苷在缺血性心脏病中的作用:对临床前心脏毒性模型的全面系统评价和荟萃分析。
J Biochem Mol Toxicol. 2025 Jul;39(7):e70365. doi: 10.1002/jbt.70365.
4
Global research trends on Chinese patent drugs inducing programmed cell death in cancer: a bibliometric analysis (1998-2024).中药诱导癌细胞程序性死亡的全球研究趋势:文献计量分析(1998 - 2024年)
Discov Oncol. 2025 Jun 21;16(1):1171. doi: 10.1007/s12672-025-02913-5.
5
In Vivo Insights into the Role of Astragaloside IV in Preventing and Treating Civilization Diseases: A Comprehensive Review.黄芪甲苷在预防和治疗文明病中的体内作用洞察:综述
Int J Mol Sci. 2025 Apr 29;26(9):4250. doi: 10.3390/ijms26094250.
6
Th1/Th2 Immune Imbalance in the Spleen of Mice Induced by Hypobaric Hypoxia Stimulation and Therapeutic Intervention of Astragaloside IV.低压低氧刺激诱导的小鼠脾脏Th1/Th2免疫失衡及黄芪甲苷IV的治疗干预
Int J Mol Sci. 2025 Mar 13;26(6):2584. doi: 10.3390/ijms26062584.
7
Astragaloside IV attenuates glucocorticoid-induced osteoclastogenesis and bone loss via the MAPK/NF-κB pathway.黄芪甲苷IV通过MAPK/NF-κB信号通路减轻糖皮质激素诱导的破骨细胞生成和骨质流失。
BMC Complement Med Ther. 2025 Feb 11;25(1):48. doi: 10.1186/s12906-025-04793-2.
8
The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity.黄芪通过抑制FLI1癌基因和增强抗肿瘤免疫力来减轻白血病。
Int J Mol Sci. 2024 Dec 14;25(24):13426. doi: 10.3390/ijms252413426.
9
A tumor targeted nano micelle carrying astragaloside IV for combination treatment of bladder cancer.载黄芪甲苷 IV 的肿瘤靶向纳米胶束用于膀胱癌的联合治疗。
Sci Rep. 2024 Jul 31;14(1):17704. doi: 10.1038/s41598-024-66010-3.
10
: A Review of Its Antitumor Effects on Non-Small Cell Lung Cancer.:其对非小细胞肺癌的抗肿瘤作用综述。
Cancer Manag Res. 2024 Jul 25;16:909-919. doi: 10.2147/CMAR.S466633. eCollection 2024.
Experimental studies on the protective effects of the overexpression of lentivirus-mediated sirtuin 6 on radiation-induced lung injury.
慢病毒介导的沉默信息调节因子 6 过表达对放射性肺损伤保护作用的实验研究。
Adv Clin Exp Med. 2020 Jul;29(7):873-877. doi: 10.17219/acem/117685.
4
MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer.MDL-800,一种 SIRT6 的别构激活剂,抑制非小细胞肺癌的增殖并增强 EGFR-TKIs 治疗效果。
Acta Pharmacol Sin. 2021 Jan;42(1):120-131. doi: 10.1038/s41401-020-0442-2. Epub 2020 Jun 15.
5
Astragaloside IV suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axis.黄芪甲苷通过调控 miR-150-5p/β-catenin 轴抑制肝癌的发展。
Environ Toxicol Pharmacol. 2020 Aug;78:103397. doi: 10.1016/j.etap.2020.103397. Epub 2020 Apr 25.
6
Silencing Sirtuin 6 induces cell cycle arrest and apoptosis in non-small cell lung cancer cell lines.沉默沉默调节蛋白6可诱导非小细胞肺癌细胞系发生细胞周期阻滞和凋亡。
Genomics. 2020 Sep;112(5):3703-3712. doi: 10.1016/j.ygeno.2020.04.027. Epub 2020 Apr 30.
7
Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion.黄芪甲苷诱导宫颈癌侵袭转移差异表达蛋白的定量蛋白质组学分析。
Cell Mol Biol Lett. 2020 Mar 31;25:25. doi: 10.1186/s11658-020-00218-9. eCollection 2020.
8
Astragaloside IV suppresses transforming growth factor-β1-induced epithelial-mesenchymal transition through inhibition of Wnt/β-catenin pathway in glioma U251 cells.黄芪甲苷IV通过抑制胶质瘤U251细胞中的Wnt/β-连环蛋白信号通路来抑制转化生长因子-β1诱导的上皮-间质转化。
Biosci Biotechnol Biochem. 2020 Jul;84(7):1345-1352. doi: 10.1080/09168451.2020.1737502. Epub 2020 Mar 10.
9
Astragaloside IV Induces Apoptosis, G-Phase Arrest and Inhibits Anti-apoptotic Signaling in Hepatocellular Carcinoma.黄芪甲苷诱导肝癌细胞凋亡、G1 期阻滞并抑制抗凋亡信号通路。
In Vivo. 2020 Mar-Apr;34(2):631-638. doi: 10.21873/invivo.11817.
10
Bcl2-Expressing Quiescent Type B Neural Stem Cells in the Ventricular-Subventricular Zone Are Resistant to Concurrent Temozolomide/X-Irradiation.室管膜下区表达 Bcl2 的静息型 B 神经干细胞对同时接受替莫唑胺/ X 射线照射具有抗性。
Stem Cells. 2019 Dec;37(12):1629-1639. doi: 10.1002/stem.3081. Epub 2019 Oct 17.